JP2015172045A5 - - Google Patents

Download PDF

Info

Publication number
JP2015172045A5
JP2015172045A5 JP2015043282A JP2015043282A JP2015172045A5 JP 2015172045 A5 JP2015172045 A5 JP 2015172045A5 JP 2015043282 A JP2015043282 A JP 2015043282A JP 2015043282 A JP2015043282 A JP 2015043282A JP 2015172045 A5 JP2015172045 A5 JP 2015172045A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
antibody
acid sequence
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015043282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015172045A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015172045A publication Critical patent/JP2015172045A/ja
Publication of JP2015172045A5 publication Critical patent/JP2015172045A5/ja
Withdrawn legal-status Critical Current

Links

JP2015043282A 2007-11-08 2015-03-05 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原 Withdrawn JP2015172045A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99625507P 2007-11-08 2007-11-08
US60/996,255 2007-11-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010533279A Division JP5710978B2 (ja) 2007-11-08 2008-11-07 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017022169A Division JP2017123851A (ja) 2007-11-08 2017-02-09 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原

Publications (2)

Publication Number Publication Date
JP2015172045A JP2015172045A (ja) 2015-10-01
JP2015172045A5 true JP2015172045A5 (enExample) 2015-12-24

Family

ID=40626453

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010533279A Active JP5710978B2 (ja) 2007-11-08 2008-11-07 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原
JP2015043282A Withdrawn JP2015172045A (ja) 2007-11-08 2015-03-05 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原
JP2017022169A Withdrawn JP2017123851A (ja) 2007-11-08 2017-02-09 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010533279A Active JP5710978B2 (ja) 2007-11-08 2008-11-07 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017022169A Withdrawn JP2017123851A (ja) 2007-11-08 2017-02-09 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原

Country Status (9)

Country Link
US (10) US7829678B2 (enExample)
EP (2) EP2217625B1 (enExample)
JP (3) JP5710978B2 (enExample)
CN (1) CN101854946B (enExample)
AU (1) AU2008323811B8 (enExample)
CA (1) CA2700197C (enExample)
ES (1) ES2883176T3 (enExample)
MX (1) MX2010004910A (enExample)
WO (1) WO2009062050A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442919T3 (es) 2007-03-27 2014-02-14 Immunovia Ab Firma/marcadores de proteínas para la detección de adenocarcinoma
EP3061462B1 (en) 2007-07-02 2019-02-27 Etubics Corporation Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
EP2190878A1 (en) * 2007-09-06 2010-06-02 Genmab A/S Novel methods and antibodies for treating cancer
CN101854946B (zh) 2007-11-08 2013-07-03 尼尔詹尼克斯肿瘤研究公司 结肠癌和胰腺癌的重组单克隆抗体和相应抗原
CA2775573A1 (en) * 2009-10-09 2011-04-14 Merck Sharp & Dohme Corp. Generation, characterization and uses thereof of anti-her 3 antibodies
US20130189268A1 (en) 2010-06-22 2013-07-25 Precision Biologics, Inc. Colon and pancreas cancer specific antigens and antibodies
SG191716A1 (en) 2010-11-19 2013-08-30 Toshio Imai Neutralizing anti-ccl20 antibodies
US9605276B2 (en) 2012-08-24 2017-03-28 Etubics Corporation Replication defective adenovirus vector in vaccination
JP6576831B2 (ja) 2012-12-28 2019-09-18 プレシジョン・バイオロジクス・インコーポレイテッド 結腸癌及び膵臓癌の診断ならびに治療のための、ヒト化モノクローナル抗体及び使用方法
US11279768B1 (en) 2015-04-03 2022-03-22 Precision Biologics, Inc. Anti-cancer antibodies, combination therapies, and uses thereof
AU2016364895A1 (en) * 2015-12-02 2018-06-07 Agenus Inc. Anti-GITR antibodies and methods of use thereof
SG10201912984WA (en) * 2015-12-02 2020-03-30 Agenus Inc Antibodies and methods of use thereof
JP2018047145A (ja) * 2016-09-23 2018-03-29 株式会社三共 スロットマシン
JP2018047147A (ja) * 2016-09-23 2018-03-29 株式会社三共 スロットマシン
JP2018047146A (ja) * 2016-09-23 2018-03-29 株式会社三共 スロットマシン
JP2018047144A (ja) * 2016-09-23 2018-03-29 株式会社三共 スロットマシン
JP2018061577A (ja) * 2016-10-11 2018-04-19 株式会社三共 スロットマシン
WO2018103062A1 (zh) * 2016-12-09 2018-06-14 深圳市盛波尔生命科学技术有限责任公司 Cnpy2异构体2及作为肠癌分子标识物的应用
BR112019021182A2 (pt) 2017-04-24 2020-06-02 Memorial Sloan Kettering Cancer Center Agentes de anticorpo anti-cd33
CA3091181A1 (en) * 2018-02-13 2019-08-22 Precision Biologics, Inc. Methods and compositions for targeting treg cells
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
US20230374150A1 (en) * 2020-10-12 2023-11-23 Memorial Sloan Kettering Cancer Center Anti-psma antibodies and uses thereof
CA3236417A1 (en) * 2021-11-05 2023-05-11 American Diagnostics & Therapy, Llc (Adxrx) Monoclonal antibodies against carcinoembryonic antigens, and their uses

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4699880A (en) 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US6190640B1 (en) 1985-04-19 2001-02-20 Ludwig Institute For Cancer Research Method for treating neoplasia using humanized antibodies which bind to antigen A33
US5851526A (en) 1985-04-19 1998-12-22 Ludwig Institute For Cancer Research Methods of treating colon cancer utilizing tumor-specific antibodies
US5431897A (en) 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4810781A (en) 1987-01-15 1989-03-07 The George Washington University Methods of preparing epitopes of tumor associated antigens
USRE39760E1 (en) 1988-03-31 2007-08-07 International Bio-Immune Systems Inc. Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
US5688657A (en) * 1988-03-31 1997-11-18 International Bio-Immune Systems, Inc. Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
AT393137B (de) 1988-10-14 1991-08-26 Biomay Biotech Prod Verfahren zum screenen einer expressions-cdna- klonbank zur auffindung von polynukleotiden
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5858725A (en) 1990-10-10 1999-01-12 Glaxo Wellcome Inc. Preparation of chimaeric antibodies using the recombinant PCR strategy
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US6307026B1 (en) 1992-12-10 2001-10-23 Celltech Limited Humanized antibodies directed against A33 antigen
US6080560A (en) 1994-07-25 2000-06-27 Monsanto Company Method for producing antibodies in plant cells
ES2197217T3 (es) * 1994-12-28 2004-01-01 University Of Kentucky Research Foundation Anticuerpo 3h1 monoclonal anti-id-murino.
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
US5811524A (en) 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US5712369A (en) 1995-08-24 1998-01-27 Ludwig Institute For Cancer Research Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein
US6417337B1 (en) * 1996-10-31 2002-07-09 The Dow Chemical Company High affinity humanized anti-CEA monoclonal antibodies
DE69833755T2 (de) 1997-05-21 2006-12-28 Biovation Ltd. Verfahren zur herstellung von nicht-immunogenen proteinen
KR20010021953A (ko) 1997-07-17 2001-03-15 추후제출 Ｂ군 수막염균 포린 및 에이치.인플루엔자 다당류를포함하는 면역원성 접합체
EA003832B1 (ru) 1997-09-15 2003-10-30 Дженетик Иммьюнити, Ллс. Ген-доставочный комплекс для чрескожной доставки чужеродного генетического материала в антиген-презентирующие клетки и способы его использования
AU760562B2 (en) 1997-12-05 2003-05-15 Scripps Research Institute, The Humanization of murine antibody
US20030167531A1 (en) 1998-07-10 2003-09-04 Russell Douglas A. Expression and purification of bioactive, authentic polypeptides from plants
US6512162B2 (en) 1998-07-10 2003-01-28 Calgene Llc Expression of eukaryotic peptides in plant plastids
US6887464B1 (en) 1999-02-02 2005-05-03 Biocache Pharmaceuticals, Inc. Advanced antigen presentation platform
US6431897B1 (en) 1999-10-06 2002-08-13 Japan Aviation Electroncis Industry Limited Connector having a rotary actuator engaged with a contact in a direction parallel to a sheet-like object connected to the connector
EP1224309A2 (en) 1999-10-21 2002-07-24 Monsanto Company Post-translational modification of recombinant proteins produced in plants
US6846488B2 (en) 2000-04-03 2005-01-25 The Uab Research Foundation Chimeric antigen-enterotoxin mucosal immunogens
US6436704B1 (en) 2000-04-10 2002-08-20 Raven Biotechnologies, Inc. Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
US8288322B2 (en) 2000-04-17 2012-10-16 Dyax Corp. Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
KR100419555B1 (ko) 2000-05-29 2004-02-19 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
US6680033B2 (en) 2000-07-25 2004-01-20 Asahi Environmental System Ltd. Composite deodorization system and ion deodorization system
US6824989B1 (en) 2000-09-01 2004-11-30 Upstate Biotechnology, Inc. Recombinant monoclonal antibody to phosphotyrosine-containing proteins
GB0029407D0 (en) 2000-12-01 2001-01-17 Affitech As Product
US6652853B2 (en) 2001-03-08 2003-11-25 Ludwig Institute For Cancer Research Method for treating cancer using A33 specific antibodies and chemotherapeutic agents
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
US20030031671A1 (en) 2001-08-01 2003-02-13 Sydney Welt Methods of treating colon cancer utilizing tumor-specific antibodies
WO2003016909A1 (en) 2001-08-16 2003-02-27 Ludwig Institute For Cancer Research Method for determining protein component in a biological sample
US20050191617A1 (en) * 2002-06-03 2005-09-01 Makoto Inoue Pramyxovirusl vectors encoding antibody and utilization thereof
DE60336149D1 (de) 2002-08-16 2011-04-07 Immunogen Inc Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln
US20070031327A1 (en) 2003-06-03 2007-02-08 Luzzi David E Nanoradiopharmaceuticals and methods of use
CN1303105C (zh) * 2003-12-08 2007-03-07 陈志南 抗人大肠癌单克隆抗体CAb—2轻、重链可变区基因及其应用
US20060040027A1 (en) * 2004-08-17 2006-02-23 Kraft Foods Holdings, Inc. Process for manufacture of grated cheese and uses thereof
CN101035564A (zh) 2004-09-10 2007-09-12 惠氏公司 人源化的抗5t4抗体和抗5t4抗体/加利车霉素缀合物
CA2604238C (en) * 2005-04-15 2015-07-07 Neogenix Oncology, Inc. Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
US20090041783A1 (en) * 2005-04-28 2009-02-12 Mochida Pharmaceutical Co., Ltd. Anti-platelet membrane glycoprotein vi monoclonal antibody
CN102875681A (zh) * 2005-07-08 2013-01-16 拜奥根Idec马萨诸塞公司 抗-αvβ6抗体及其用途
KR101544108B1 (ko) 2006-09-08 2015-08-13 애브비 바하마스 리미티드 인터루킨-13 결합 단백질
CN101854946B (zh) * 2007-11-08 2013-07-03 尼尔詹尼克斯肿瘤研究公司 结肠癌和胰腺癌的重组单克隆抗体和相应抗原
US20130189268A1 (en) * 2010-06-22 2013-07-25 Precision Biologics, Inc. Colon and pancreas cancer specific antigens and antibodies
US11279768B1 (en) * 2015-04-03 2022-03-22 Precision Biologics, Inc. Anti-cancer antibodies, combination therapies, and uses thereof

Similar Documents

Publication Publication Date Title
JP2015172045A5 (enExample)
JP2011502517A5 (enExample)
JP2008538289A5 (enExample)
US10494435B2 (en) Human monoclonal antibodies specific for CD22
RU2377252C2 (ru) Rg1 антитела и их применение
US9803022B2 (en) Mesothelin domain-specific monoclonal antibodies and use thereof
JP2010518847A5 (enExample)
Fukukawa et al. Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10
JP2010510809A5 (enExample)
JP2019535670A5 (enExample)
JP2016138129A5 (enExample)
JP2016500655A5 (enExample)
JP2018042573A5 (enExample)
Jain et al. The development of a recombinant scFv monoclonal antibody targeting canine CD20 for use in comparative medicine
CN113382750B (zh) Cdcp1靶向疗法
JP2011509079A5 (enExample)
JP2013506428A5 (enExample)
JP2006204290A5 (enExample)
Carneiro et al. A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours
JP2011501946A5 (enExample)
JP2020518243A5 (enExample)
JP6928602B2 (ja) 機能的な癌標的として、糖脂質ではなく糖タンパク質上で発現させたシアリル−ジ−ルイスａ及びそれに対する抗体
Nicolaides et al. NAV-001, a high-efficacy antibody-drug conjugate targeting mesothelin with improved delivery of a potent payload by counteracting MUC16/CA125 inhibitory effects
JPWO2019169212A5 (enExample)
Asgarov et al. A new anti-mesothelin antibody targets selectively the membrane-associated form